Article
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Aug 2006
Wu Xifeng, Gu Jian, Wu Tsung-Teh, Swisher Stephen G, Liao Zhongxin, Correa Arlene M, Liu Jun, Etzel Carol J, Amos Christopher I, Huang Maosheng, Chiang Silvia S, Milas Luke, Hittelman Walter N, Ajani Jaffer A
Abstract excerpt
PURPOSE: Understanding how specific genetic variants modify drug action pathways may provide informative blueprints for individualized chemotherapy. METHODS: We applied a pathway-based approach to examine the impact of a comprehensive panel of genetic polymorphisms on clinical outcomes in 210 esophageal cancer patients. RESULTS: In the Cox proportional hazards model, MTHFR Glu429Ala variant genotypes were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
